Pre-emptive Treatment of Severe Nausea and Vomiting of Pregnancy
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether pre-emptive use of a delayed release
combination of pyridoxine hydrochloride and doxylamine succinate (Diclectin®), before
eruption of symptoms of Nausea and vomiting of pregnancy and hyperemesis gravidarum, will
reduce the incidence of severe forms of this syndrome/HG.
Phase:
Phase 3
Details
Lead Sponsor:
The Hospital for Sick Children
Collaborator:
Duchesnay Inc.
Treatments:
Dicyclomine Dicyclomine, doxylamine, pyridoxine drug combination Doxylamine Pyridoxine